Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Keywords Research group - Any -Cell Virology and Immunology (VIC)Immunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Adrià ComellasAleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAmaya Blanco PereraAna GervassiAnaí Villanueva DelgadoAnna Pineda MicolaAnna Pons GrifolsAnto Benavides RuizArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Julià i LlobregatCarla Rovirosa MartíCarla Sánchez RuizCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina Benitez RodríguezCristina Hurtado TripianaCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoCristina Saiz MasvidalCristina Val CidDavid Jara CondoDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisa Molina MolinaEloi Franco Trepat Ester Aparicio PratsEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Armendariz BurgoaEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancesc Cunyat ViaplanaFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGabriel Rodrigo MartínezGerard Campos GonzalezGooya BanaeiGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroIrene Silva RuizIris TeubelItziar Erkizia JauregiIu Raïch Panisello Jacopo Faranda CordellaJakub ChojnackiJavier Martínez-PicadoJeremy Tessier Joan Pagès OliverasJon Izquierdo PujolJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Ferrer CendraLidia Garrido SanzLidia Ruiz TabuencaLourdes Grau ParéLucía Gómez EspadaMacedonia Trigueros PeñaMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Martinez VelascoMarina Matilla MartínezMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarkus MartincicMarta Massanella LunaMarta Ruiz RiolMaría Lázaro DíezMireia Martínez GameroMª Belén Gómez HornillosMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNel Marín SánchezNuria Izquierdo UserosNúria de la Iglesia ZaragozaOriol Careta BorràsPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSanae El Bouhali Sandra Franco CireraSantiago Cavero MartínezSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSonia Villanueva HernándezSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaThuong NguyenTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÀlex Pérez Hita From date To date Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII Genomic epidemiology of SARS-CoV-2 in Catalonia: virologic surveillance and outbreak control Project status Ongoing Start/End 2021 / 2023 Principal investigator Marc Noguera i Julian Participating entities IrsiCaixa, IGTP Strategic lines Cancer Emerging infectious diseases Financing entity Fundació "La Marató" de TV3 Eclipse Ts2R-FL Inverted Research Microscope Project status Ongoing Start/End 2021 / 2024 Principal investigator Christian Brander Participating entities IrsiCaixa Financing entity Dormeur Foundation, Vaduz In vitro antiviral screening of compounds provided by Pharma Mar on Ebola virus entry and on the replication of HIV-1, Zika and SARS-CoV-2 Project status Ongoing Start/End 2021 / 2022 Principal investigator Ester Ballana Guix Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity PharmaMar Impact of HIV envelope function and antigenicity on elite control of HIV replication Project status Ongoing Start/End 2021 / 2023 Principal investigator Julià Blanco Arbués Participating entities IrsiCaixa AIDS Research Institute, ISCII, Institut de Recerca Germans Trias i Pujol Strategic lines Immunopathology Financing entity ISCIII EU Research Scholars Program in HIV Project status Ongoing Start/End 2021 / 2023 Principal investigator Sara Morón López Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity GILEAD Discovery of novel inhibitors of HIV-1 RNA biogenesis based on the inhibition of the ribonucleoprotein RRE-Rev Project status Ongoing Start/End 2021 / 2024 Principal investigator Javier Martínez-Picado External researchers José Alcamí, Vicente Marchán Participating entities IrsiCaixa, ISCIII, University of Barcelona, Catholic University of Valencia Strategic lines Therapies and vaccines Reversing Immune Dysfunction for HIV-1 eradication Project status Ongoing Start/End 2021 / 2026 Principal investigator Javier Martínez-Picado Maria Salgado Bernal Participating entities IrsiCaixa, Emory University, University of Southern California, Scripps Research College Strategic lines Global infectious diseases Financing entity National Institutes of Health (NIH) Impact of synonymous HIV-1 genome recoding on virus immune response and latency Project status Ongoing Start/End 2020 / 2023 Participating entities IrsiCaixa AIDS Research Institute Strategic lines Immunopathology Financing entity Spanish Ministry of Science and Innovation (PID2019-103955RB-100) Elimination of the HIV latent reservoir by using novel anti-CD4 chimeric antigen receptor T cells Project status Ongoing Start/End 2021 / 2024 Principal investigator Maria Salgado Bernal Participating entities IrsiCaixa, Josep Carreras Leukaemia Research Institute Strategic lines Immunopathology Financing entity Spanish Ministry of Science and Innovation Reference PID2020-115931RA-I00 Pagination First Previous Page 1 Page 2 Page 3 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII
Genomic epidemiology of SARS-CoV-2 in Catalonia: virologic surveillance and outbreak control Project status Ongoing Start/End 2021 / 2023 Principal investigator Marc Noguera i Julian Participating entities IrsiCaixa, IGTP Strategic lines Cancer Emerging infectious diseases Financing entity Fundació "La Marató" de TV3
Eclipse Ts2R-FL Inverted Research Microscope Project status Ongoing Start/End 2021 / 2024 Principal investigator Christian Brander Participating entities IrsiCaixa Financing entity Dormeur Foundation, Vaduz
In vitro antiviral screening of compounds provided by Pharma Mar on Ebola virus entry and on the replication of HIV-1, Zika and SARS-CoV-2 Project status Ongoing Start/End 2021 / 2022 Principal investigator Ester Ballana Guix Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity PharmaMar
Impact of HIV envelope function and antigenicity on elite control of HIV replication Project status Ongoing Start/End 2021 / 2023 Principal investigator Julià Blanco Arbués Participating entities IrsiCaixa AIDS Research Institute, ISCII, Institut de Recerca Germans Trias i Pujol Strategic lines Immunopathology Financing entity ISCIII
EU Research Scholars Program in HIV Project status Ongoing Start/End 2021 / 2023 Principal investigator Sara Morón López Participating entities IrsiCaixa Strategic lines Global infectious diseases Financing entity GILEAD
Discovery of novel inhibitors of HIV-1 RNA biogenesis based on the inhibition of the ribonucleoprotein RRE-Rev Project status Ongoing Start/End 2021 / 2024 Principal investigator Javier Martínez-Picado External researchers José Alcamí, Vicente Marchán Participating entities IrsiCaixa, ISCIII, University of Barcelona, Catholic University of Valencia Strategic lines Therapies and vaccines
Reversing Immune Dysfunction for HIV-1 eradication Project status Ongoing Start/End 2021 / 2026 Principal investigator Javier Martínez-Picado Maria Salgado Bernal Participating entities IrsiCaixa, Emory University, University of Southern California, Scripps Research College Strategic lines Global infectious diseases Financing entity National Institutes of Health (NIH)
Impact of synonymous HIV-1 genome recoding on virus immune response and latency Project status Ongoing Start/End 2020 / 2023 Participating entities IrsiCaixa AIDS Research Institute Strategic lines Immunopathology Financing entity Spanish Ministry of Science and Innovation (PID2019-103955RB-100)
Elimination of the HIV latent reservoir by using novel anti-CD4 chimeric antigen receptor T cells Project status Ongoing Start/End 2021 / 2024 Principal investigator Maria Salgado Bernal Participating entities IrsiCaixa, Josep Carreras Leukaemia Research Institute Strategic lines Immunopathology Financing entity Spanish Ministry of Science and Innovation Reference PID2020-115931RA-I00